Selectis Health (GBCS)
OTHER OTC:GBCS
US Market
Holding GBCS?
Track your performance easily

Selectis Health (GBCS) Income Statement

2 Followers

Selectis Health Income Statement

Last quarter (Q ), Selectis Health's total revenue was $9.58M, an increase of 7.35% from the same quarter last year. In Q, Selectis Health's net income was $786.84K. See Selectis Health’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 37.33M$ 35.17M$ 37.33M$ 27.77M$ 19.55M$ 6.93M
Cost of Revenue
$ 22.94M$ 31.38M$ 29.86M$ 21.47M$ 13.38M-
Gross Profit
$ 14.38M$ 3.80M$ 7.47M$ 6.30M$ 6.16M$ 6.93M
Operating Expense
$ 23.82M$ 45.74M$ 40.89M$ 30.02M$ 17.55M$ -5.63M
Operating Income
$ -6.87M$ -8.96M$ -286.57K$ -728.99K$ 3.37M$ 1.30M
Net Non Operating Interest Income Expense
$ -1.67M$ -2.17M$ -2.23M$ -2.50M$ -2.14M$ -2.49M
Other Income Expense
$ -1.94M$ -296.44K$ -121.99K$ -152.25K$ -1.73M$ 1.07K
Pretax Income
$ -7.17M$ -3.97M$ -2.40M$ -3.07M$ 2.96M$ -1.19M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -6.17M$ -4.00M$ -2.43M$ -2.28M$ 2.93M$ -2.08M
Basic EPS
$ -2.02$ -1.31$ -0.79$ -0.82$ 1.10$ -0.30
Diluted EPS
$ -2.02$ -1.31$ -0.79$ -0.82$ 1.10$ -0.30
Basic Average Shares
$ 12.24M$ 3.05M$ 3.05M$ 2.77M$ 2.72M$ 2.73M
Diluted Average Shares
$ 12.24M$ 3.05M$ 3.05M$ 2.77M$ 2.76M$ 2.73M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 23.82M$ 45.74M$ 40.89M$ 30.02M$ 17.55M$ -5.63M
Net Income From Continuing And Discontinued Operation
$ -6.14M$ -3.97M$ -2.40M$ -2.25M$ 2.96M$ -2.05M
Normalized Income
$ 18.49M-$ -1.89M---
Interest Expense
------
EBIT
$ -3.84M$ -1.80M$ -164.58K$ -576.75K$ 5.10M$ 944.64K
EBITDA
$ -2.20M$ -131.02K$ 1.63M$ 1.99M$ 6.68M$ 2.43M
Currency in USD

Selectis Health Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis